Close



Oct 4, 2023 07:00AM
Sep 28, 2023 12:02PM
Aug 9, 2023 07:00AM
Jul 31, 2023 07:05AM
Jul 28, 2023 07:05AM
Jul 28, 2023 07:05AM
Jul 10, 2023 07:05AM Ionis Pharmaceuticals (IONS) Reports Eplontersen Continued to Show Improvement in ATTRv-PN through 85 weeks
Jul 10, 2023 07:05AM
Apr 24, 2023 07:01AM
Apr 24, 2023 07:00AM
Mar 27, 2023 05:49AM
Mar 27, 2023 02:00AM
Mar 23, 2023 05:31AM
Mar 22, 2023 11:01PM Ionis accounces FDA advisory committee voted unanimously for a potential accelerated approval of tofersen for SOD1-ALS
Mar 7, 2023 07:06AM
Mar 7, 2023 07:05AM
Feb 22, 2023 07:01AM
Jan 26, 2023 09:30AM
Dec 5, 2022 07:34AM
Dec 5, 2022 07:30AM
Nov 9, 2022 07:00AM Ionis reports third quarter financial results
Aug 9, 2022 07:00AM
Jul 26, 2022 07:31AM
Jul 26, 2022 07:30AM
Jan 30, 2020 11:13AM
May 1, 2019 07:30AM
Aug 6, 2018 04:05PM
Aug 6, 2018 04:05PM Akcea Reports Financial Results and Highlights for Second Quarter 2018
Aug 2, 2018 08:00AM
Jul 11, 2018 07:31AM
Jul 11, 2018 07:30AM
Jul 11, 2018 07:30AM
Jul 11, 2018 07:30AM
Jul 5, 2018 07:02AM
Jul 5, 2018 07:00AM New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI™ (inotersen) for the Treatment of Hereditary ATTR Amyloidosis
May 11, 2018 09:20AM
May 10, 2018 06:21PM
May 10, 2018 06:21PM
May 7, 2018 07:21AM
May 4, 2018 07:00AM
May 3, 2018 04:05PM
May 3, 2018 04:05PM Akcea Reports Financial Results and Highlights for First Quarter 2018
Apr 26, 2018 04:05PM
Apr 26, 2018 04:05PM
Feb 15, 2018 04:28PM
Feb 15, 2018 04:05PM
Feb 15, 2018 04:05PM
Jan 8, 2018 07:04AM
Jan 8, 2018 07:00AM Ionis' Inotersen NDA Accepted for Priority Review by the FDA
Dec 20, 2017 09:25AM

11,826 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All